Clinical Trials Directory

Trials / Completed

CompletedNCT02511145

Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration

Exploratory Study to Compare Mechanical Penetration Enhancers on Metvixia Skin Penetration

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Exploratory, mono-center, randomized, intra-individual, controlled trial involving healthy volunteers to compare the effect on MAL penetration into the skin following various mechanical penetration enhancement techniques.

Detailed description

At baseline, each mini-zone was selected and randomly assigned to a pretreatment: 3 zones with microneedling Dermaroller®, 3 zones with ablative fractional CO2 Laser, and 3 zones with no pretreatment. After performing pretreatment, MAL cream was applied on the 6 assigned mini-zones for 3 hours incubation. Each condition was tested with and without occlusion. The three mini-zones with no product applied were used to perform biophysics measures.

Conditions

Interventions

TypeNameDescription
OTHERocclusive bandage
DEVICEablative fractional CO2 laser pretreatment
DEVICEMicroneedles pretreatment
DRUGMETVIXIA Cream

Timeline

Start date
2014-02-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2015-07-29
Last updated
2015-07-31

Source: ClinicalTrials.gov record NCT02511145. Inclusion in this directory is not an endorsement.